Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × SCLC × ceralasertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 SCLC 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 High Grade Serous Carcinoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Advanced Solid Malignancies 1

Interventions

sintilimab 1 olaparib 1 ceralasertib 1 Etoposide 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03428607 2021-02-18

Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2]

Samsung Medical Center

Phase 2 Completed

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡